Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group.
ENIGMA
amygdala
hippocampus
major depressive disorder (MDD)
nucleus accumbens
shape analysis
Journal
Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
01
03
2020
received:
30
12
2019
accepted:
06
03
2020
pubmed:
22
3
2020
medline:
29
3
2022
entrez:
22
3
2020
Statut:
ppublish
Résumé
Alterations in regional subcortical brain volumes have been investigated as part of the efforts of an international consortium, ENIGMA, to identify reliable neural correlates of major depressive disorder (MDD). Given that subcortical structures are comprised of distinct subfields, we sought to build significantly from prior work by precisely mapping localized MDD-related differences in subcortical regions using shape analysis. In this meta-analysis of subcortical shape from the ENIGMA-MDD working group, we compared 1,781 patients with MDD and 2,953 healthy controls (CTL) on individual measures of shape metrics (thickness and surface area) on the surface of seven bilateral subcortical structures: nucleus accumbens, amygdala, caudate, hippocampus, pallidum, putamen, and thalamus. Harmonized data processing and statistical analyses were conducted locally at each site, and findings were aggregated by meta-analysis. Relative to CTL, patients with adolescent-onset MDD (≤ 21 years) had lower thickness and surface area of the subiculum, cornu ammonis (CA) 1 of the hippocampus and basolateral amygdala (Cohen's d = -0.164 to -0.180). Relative to first-episode MDD, recurrent MDD patients had lower thickness and surface area in the CA1 of the hippocampus and the basolateral amygdala (Cohen's d = -0.173 to -0.184). Our results suggest that previously reported MDD-associated volumetric differences may be localized to specific subfields of these structures that have been shown to be sensitive to the effects of stress, with important implications for mapping treatments to patients based on specific neural targets and key clinical features.
Identifiants
pubmed: 32198905
doi: 10.1002/hbm.24988
pmc: PMC8675412
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-351Subventions
Organisme : NIA NIH HHS
ID : T32 AG058507
Pays : United States
Organisme : NIMH NIH HHS
ID : K01MH117442
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH117442
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059874
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : NIMH NIH HHS
ID : R37 MH101495
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41EB015922
Pays : United States
Organisme : NIA NIH HHS
ID : R56AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG059874
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH116147
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111671
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH117601
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54EB020403
Pays : United States
Organisme : NIA NIH HHS
ID : T32AG058507
Pays : United States
Organisme : NIMH NIH HHS
ID : T32MH073526
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH117601
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH111671
Pays : United States
Organisme : NIMH NIH HHS
ID : R37MH101495
Pays : United States
Informations de copyright
© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc.
Références
Neuropsychopharmacology. 2010 Jan;35(1):4-26
pubmed: 19812543
J Neuroendocrinol. 2002 Nov;14(11):911-23
pubmed: 12421345
Ann N Y Acad Sci. 2007 Dec;1121:499-527
pubmed: 17872395
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Physiol Behav. 2010 Feb 9;99(2):186-93
pubmed: 19786041
J Affect Disord. 2016 Apr;194:21-9
pubmed: 26802503
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Soc Cogn Affect Neurosci. 2019 Nov 1;14(11):1159-1166
pubmed: 31680163
J Psychiatr Res. 2017 Mar;86:58-65
pubmed: 27918926
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1178-1188
pubmed: 31634568
Hum Brain Mapp. 2022 Jan;43(1):341-351
pubmed: 32198905
Curr Opin Neurobiol. 2004 Dec;14(6):769-76
pubmed: 15582382
J Steroid Biochem. 1986 Nov;25(5B):717-21
pubmed: 3807360
PLoS One. 2013 Apr 09;8(4):e60650
pubmed: 23585842
J Affect Disord. 2010 Oct;126(1-2):272-7
pubmed: 20392498
Biol Psychiatry. 2009 May 1;65(9):812-8
pubmed: 19028381
Bipolar Disord. 2017 Feb;19(1):41-49
pubmed: 28239952
Brain Struct Funct. 2016 Jan;221(1):171-84
pubmed: 25287512
Am J Psychiatry. 2004 Jul;161(7):1270-7
pubmed: 15229061
Curr Opin Psychiatry. 2015 Jan;28(1):7-12
pubmed: 25415499
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):E563-72
pubmed: 22331913
J Neurophysiol. 2015 Jan 1;113(1):4-13
pubmed: 25339705
Mol Psychiatry. 2017 Sep;22(9):1352-1358
pubmed: 28115740
Hum Brain Mapp. 2018 Jun;39(6):2500-2513
pubmed: 29468773
Psychol Med. 2014 Oct;44(14):2927-37
pubmed: 25065859
Depress Anxiety. 2013 Jun;30(6):515-27
pubmed: 23468126
J Psychiatr Res. 2009 Sep;43(13):1112-7
pubmed: 19394960
Transl Psychiatry. 2017 May 2;7(5):e1116
pubmed: 28463239
Annu Rev Psychol. 2002;53:545-74
pubmed: 11752496
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
Transl Psychiatry. 2020 May 29;10(1):172
pubmed: 32472038
Sci Rep. 2016 Feb 16;6:21227
pubmed: 26880358
Mol Psychiatry. 2008 Nov;13(11):993-1000
pubmed: 18504424
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Neuroimage. 2016 Mar;128:125-137
pubmed: 26747746
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22445-50
pubmed: 20080793
Am J Psychiatry. 2009 Jun;166(6):702-10
pubmed: 19411368
Neuroimage. 2011 Jun 15;56(4):1993-2010
pubmed: 21440071
Biol Psychiatry. 2013 Jul 1;74(1):62-8
pubmed: 23419546
Psychol Med. 2012 Apr;42(4):671-81
pubmed: 21910935
Front Neuroinform. 2019 Jan 08;12:102
pubmed: 30670959
J Anat. 2005 Sep;207(3):271-82
pubmed: 16185252
Biol Psychiatry. 2019 Mar 15;85(6):487-497
pubmed: 30528746
ASN Neuro. 2009 Nov 10;1(4):
pubmed: 19843010
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Proc IEEE Int Symp Biomed Imaging. 2015 Apr;2015:1402-1406
pubmed: 26413211
Transl Psychiatry. 2014 Apr 08;4:e378
pubmed: 24713859
Neuroimage. 2016 Apr 1;129:1-14
pubmed: 26824403
Nat Commun. 2016 Dec 15;7:13738
pubmed: 27976715
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5233-E5242
pubmed: 29760060
Nat Neurosci. 2015 Oct;18(10):1353-63
pubmed: 26404710
Curr Opin Psychol. 2015 Aug;4:6-12
pubmed: 25642446
Biol Psychiatry. 2015 Feb 1;77(3):285-294
pubmed: 25109665
Annu Rev Clin Psychol. 2005;1:293-319
pubmed: 17716090
J Neurosci. 2010 Dec 1;30(48):16197-207
pubmed: 21123566
Neuroimage. 2007 Oct 15;38(1):43-56
pubmed: 17825583
Nature. 2015 Apr 9;520(7546):224-9
pubmed: 25607358
Learn Mem. 2015 Aug 18;22(9):411-6
pubmed: 26286651
Neuroimage. 2018 Apr 15;170:182-198
pubmed: 28259781
Neuropsychopharmacology. 2010 Jul;35(8):1743-50
pubmed: 20357761
Cell. 2018 Oct 18;175(3):723-735.e16
pubmed: 30340041
Transl Psychiatry. 2020 Mar 20;10(1):100
pubmed: 32198361
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573